Cargando…

Fragility fractures in Europe: burden, management and opportunities

SUMMARY: This report provides an overview and a comparison of the burden and management of fragility fractures in the largest five countries of the European Union plus Sweden (EU6). In 2017, new fragility fractures in the EU6 are estimated at 2.7 million with an associated annual cost of €37.5 billi...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgström, Fredrik, Karlsson, Linda, Ortsäter, Gustav, Norton, Nicolas, Halbout, Philippe, Cooper, Cyrus, Lorentzon, Mattias, McCloskey, Eugene V., Harvey, Nicholas C., Javaid, Muhamamd K., Kanis, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166207/
https://www.ncbi.nlm.nih.gov/pubmed/32306163
http://dx.doi.org/10.1007/s11657-020-0706-y
_version_ 1783523512699322368
author Borgström, Fredrik
Karlsson, Linda
Ortsäter, Gustav
Norton, Nicolas
Halbout, Philippe
Cooper, Cyrus
Lorentzon, Mattias
McCloskey, Eugene V.
Harvey, Nicholas C.
Javaid, Muhamamd K.
Kanis, John A.
author_facet Borgström, Fredrik
Karlsson, Linda
Ortsäter, Gustav
Norton, Nicolas
Halbout, Philippe
Cooper, Cyrus
Lorentzon, Mattias
McCloskey, Eugene V.
Harvey, Nicholas C.
Javaid, Muhamamd K.
Kanis, John A.
author_sort Borgström, Fredrik
collection PubMed
description SUMMARY: This report provides an overview and a comparison of the burden and management of fragility fractures in the largest five countries of the European Union plus Sweden (EU6). In 2017, new fragility fractures in the EU6 are estimated at 2.7 million with an associated annual cost of €37.5 billion and a loss of 1.0 million quality-adjusted life years. INTRODUCTION: Osteoporosis is characterized by reduced bone mass and strength, which increases the risk of fragility fractures, which in turn, represent the main consequence of the disease. This report provides an overview and a comparison of the burden and management of fragility fractures in the largest five EU countries and Sweden (designated the EU6). METHODS: A series of metrics describing the burden and management of fragility fractures were defined by a scientific steering committee. A working group performed the data collection and analysis. Data were collected from current literature, available retrospective data and public sources. Different methods were applied (e.g. standard statistics and health economic modelling), where appropriate, to perform the analysis for each metric. RESULTS: Total fragility fractures in the EU6 are estimated to increase from 2.7 million in 2017 to 3.3 million in 2030; a 23% increase. The resulting annual fracture-related costs (€37.5 billion in 2017) are expected to increase by 27%. An estimated 1.0 million quality-adjusted life years (QALYs) were lost in 2017 due to fragility fractures. The current disability-adjusted life years (DALYs) per 1000 individuals age 50 years or more were estimated at 21 years, which is higher than the estimates for stroke or chronic obstructive pulmonary disease. The treatment gap (percentage of eligible individuals not receiving treatment with osteoporosis drugs) in the EU6 is estimated to be 73% for women and 63% for men; an increase of 17% since 2010. If all patients who fracture in the EU6 were enrolled into fracture liaison services, at least 19,000 fractures every year might be avoided. CONCLUSIONS: Fracture-related burden is expected to increase over the coming decades. Given the substantial treatment gap and proven cost-effectiveness of fracture prevention schemes such as fracture liaison services, urgent action is needed to ensure that all individuals at high risk of fragility fracture are appropriately assessed and treated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11657-020-0706-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7166207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-71662072020-04-24 Fragility fractures in Europe: burden, management and opportunities Borgström, Fredrik Karlsson, Linda Ortsäter, Gustav Norton, Nicolas Halbout, Philippe Cooper, Cyrus Lorentzon, Mattias McCloskey, Eugene V. Harvey, Nicholas C. Javaid, Muhamamd K. Kanis, John A. Arch Osteoporos Original Article SUMMARY: This report provides an overview and a comparison of the burden and management of fragility fractures in the largest five countries of the European Union plus Sweden (EU6). In 2017, new fragility fractures in the EU6 are estimated at 2.7 million with an associated annual cost of €37.5 billion and a loss of 1.0 million quality-adjusted life years. INTRODUCTION: Osteoporosis is characterized by reduced bone mass and strength, which increases the risk of fragility fractures, which in turn, represent the main consequence of the disease. This report provides an overview and a comparison of the burden and management of fragility fractures in the largest five EU countries and Sweden (designated the EU6). METHODS: A series of metrics describing the burden and management of fragility fractures were defined by a scientific steering committee. A working group performed the data collection and analysis. Data were collected from current literature, available retrospective data and public sources. Different methods were applied (e.g. standard statistics and health economic modelling), where appropriate, to perform the analysis for each metric. RESULTS: Total fragility fractures in the EU6 are estimated to increase from 2.7 million in 2017 to 3.3 million in 2030; a 23% increase. The resulting annual fracture-related costs (€37.5 billion in 2017) are expected to increase by 27%. An estimated 1.0 million quality-adjusted life years (QALYs) were lost in 2017 due to fragility fractures. The current disability-adjusted life years (DALYs) per 1000 individuals age 50 years or more were estimated at 21 years, which is higher than the estimates for stroke or chronic obstructive pulmonary disease. The treatment gap (percentage of eligible individuals not receiving treatment with osteoporosis drugs) in the EU6 is estimated to be 73% for women and 63% for men; an increase of 17% since 2010. If all patients who fracture in the EU6 were enrolled into fracture liaison services, at least 19,000 fractures every year might be avoided. CONCLUSIONS: Fracture-related burden is expected to increase over the coming decades. Given the substantial treatment gap and proven cost-effectiveness of fracture prevention schemes such as fracture liaison services, urgent action is needed to ensure that all individuals at high risk of fragility fracture are appropriately assessed and treated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11657-020-0706-y) contains supplementary material, which is available to authorized users. Springer London 2020-04-19 2020 /pmc/articles/PMC7166207/ /pubmed/32306163 http://dx.doi.org/10.1007/s11657-020-0706-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Borgström, Fredrik
Karlsson, Linda
Ortsäter, Gustav
Norton, Nicolas
Halbout, Philippe
Cooper, Cyrus
Lorentzon, Mattias
McCloskey, Eugene V.
Harvey, Nicholas C.
Javaid, Muhamamd K.
Kanis, John A.
Fragility fractures in Europe: burden, management and opportunities
title Fragility fractures in Europe: burden, management and opportunities
title_full Fragility fractures in Europe: burden, management and opportunities
title_fullStr Fragility fractures in Europe: burden, management and opportunities
title_full_unstemmed Fragility fractures in Europe: burden, management and opportunities
title_short Fragility fractures in Europe: burden, management and opportunities
title_sort fragility fractures in europe: burden, management and opportunities
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166207/
https://www.ncbi.nlm.nih.gov/pubmed/32306163
http://dx.doi.org/10.1007/s11657-020-0706-y
work_keys_str_mv AT borgstromfredrik fragilityfracturesineuropeburdenmanagementandopportunities
AT karlssonlinda fragilityfracturesineuropeburdenmanagementandopportunities
AT ortsatergustav fragilityfracturesineuropeburdenmanagementandopportunities
AT nortonnicolas fragilityfracturesineuropeburdenmanagementandopportunities
AT halboutphilippe fragilityfracturesineuropeburdenmanagementandopportunities
AT coopercyrus fragilityfracturesineuropeburdenmanagementandopportunities
AT lorentzonmattias fragilityfracturesineuropeburdenmanagementandopportunities
AT mccloskeyeugenev fragilityfracturesineuropeburdenmanagementandopportunities
AT harveynicholasc fragilityfracturesineuropeburdenmanagementandopportunities
AT javaidmuhamamdk fragilityfracturesineuropeburdenmanagementandopportunities
AT kanisjohna fragilityfracturesineuropeburdenmanagementandopportunities
AT fragilityfracturesineuropeburdenmanagementandopportunities